Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Non-Small Cell Lung Cancer”

361 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 361 results

Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Testing effectiveness (Phase 2)Study completedNCT00497315
What this trial is testing

Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Antwerp 30
Testing effectiveness (Phase 2)Ended earlyNCT01313663
What this trial is testing

Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT02716038
What this trial is testing

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Columbia University 39
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Testing effectiveness (Phase 2)UnknownNCT04762030
What this trial is testing

Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 39
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Testing effectiveness (Phase 2)Looking for participantsNCT06379087
What this trial is testing

Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Ji Yongling 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07309952
What this trial is testing

Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC

Who this might be right for
Locally Advanced Non-Small Cell Lung CancerStage IIIb Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer
Yang Hong 28
Testing effectiveness (Phase 2)Study completedNCT03086733
What this trial is testing

Phase II Lung Metcore - Preoperative Metformin for Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung Cancer
University Health Network, Toronto 28
Early research (Phase 1)Ended earlyNCT04348292
What this trial is testing

Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+7 more
Emory University 3
Not applicableStudy completedNCT06735781
What this trial is testing

Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 101
Early research (Phase 1)Ended earlyNCT02987998
What this trial is testing

Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
Nathan Pennell, MD, PhD 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375109
What this trial is testing

PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Beijing Chest Hospital, Capital Medical University 60
Testing effectiveness (Phase 2)Ended earlyNCT04422392
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 93
Testing effectiveness (Phase 2)Ended earlyNCT00293332
What this trial is testing

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Lung Cancer
University of California, San Francisco 1
Testing effectiveness (Phase 2)UnknownNCT05987826
What this trial is testing

Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04470076
What this trial is testing

Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation

Who this might be right for
Non Small Cell Lung CancerSurgeryEGFR Activating Mutation+2 more
Fifth Affiliated Hospital, Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06734182
What this trial is testing

Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 25
Testing effectiveness (Phase 2)Ended earlyNCT01138722
What this trial is testing

Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial

Who this might be right for
Early Stage Non-small Cell Lung Cancer
University Hospital, Ghent 1
Load More Results